1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RAB23 CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA PRPS1 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA PFN2 CTRPv2 pan-cancer AAC -0.19 8e-06
mRNA TFE3 CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA C16orf87 CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA MAP4K1 CTRPv2 pan-cancer AAC -0.18 7e-05
mRNA TMEM263 CTRPv2 pan-cancer AAC -0.18 6e-06
mRNA SKA1 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA LOXL2 CTRPv2 pan-cancer AAC -0.17 4e-05
mRNA WDR76 CTRPv2 pan-cancer AAC -0.17 7e-06
Download CSV